The Ministry of Finance on October 08, 2024, issued the notification regarding the amendment to notification no. 1/2017-Central Tax (Rate) dated June 28, 2017 which states “CGST Rate Schedule”
The following has been stated namely: -
• Schedule I – 2.5% in List 1, after item number 232 the following has been inserted namely: -
“(233) Trastuzumab Deruxtecan
(234) Osimertinib
(235) Durvalumab”
• Schedule II – 6%, after S. No. 32B the following has been inserted namely: -
“32 C - Extruded or expanded products, savoury or salted (other than un-fried or un-cooked snack pellets, by whatever name called, manufactured through process of extrusion)”
• Schedule IV – 14%, after S. No. 210 the following has been inserted namely: -
“210A – Seats of a kind used for motor vehicles”
This shall come into force on October 10, 2024.
[Notification No. 05/2024-Central Tax (Rate)]
